A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Ohio State University Comprehensive Cancer Center
Yale University
Incyte Corporation
Mayo Clinic
National Institutes of Health Clinical Center (CC)
Ossium Health, Inc.
Ohio State University Comprehensive Cancer Center
City of Hope Medical Center
Institute of Hematology & Blood Diseases Hospital, China
UNC Lineberger Comprehensive Cancer Center
Mayo Clinic
Ohio State University Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
Kymera Therapeutics, Inc.
Ohio State University Comprehensive Cancer Center
Bio-Path Holdings, Inc.
National Cancer Institute (NCI)
Daiichi Sankyo
Columbia University
Mundipharma Research Limited
Kyowa Kirin Co., Ltd.
City of Hope Medical Center
Pfizer
City of Hope Medical Center
Wake Forest University Health Sciences
Stanford University
Stanford University
University of Nebraska
University of Nebraska
Children's Oncology Group
University of Nebraska
Eastern Cooperative Oncology Group
Atara Biotherapeutics
Karyopharm Therapeutics Inc
Columbia University
Roswell Park Cancer Institute
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
Alexion Pharmaceuticals, Inc.
Rutgers, The State University of New Jersey
Northwestern University
Northwestern University
Roswell Park Cancer Institute
AbbVie